| I-28 Siak-Leng CHOI Applying a quantitative system pharmacology (QSP) model to inform KRASG12C covalent inhibitors’ PK driver level needed for efficacy in patients with non-small cell lung cancer (NSCLC) Wednesday 10:00-11:30 |
| I-28 Siak-Leng CHOI Applying a quantitative system pharmacology (QSP) model to inform KRASG12C covalent inhibitors’ PK driver level needed for efficacy in patients with non-small cell lung cancer (NSCLC) Wednesday 10:00-11:30 |